Male Infertility: Management of Infertile Men in Reproductive Medicine. Dieser Artikel ist nicht verfügbar.Male Infertility: Management of Infertile Men in Reproductive Medicine

**Selected for 2026 Doody's Core Titles in Urology**

Despite the fact that about half of infertility problems stem from male factors, gynecologists are often the first health care providers to perform the initial assessment of the infertile couple. For this reason, it is critical that gynecologists and reproductive medicine specialists remain up to date on the primary conditions that cause male infertility, as well as current diagnostic tools and treatment options of both natural and assisted conception. From diagnosis through treatment, Male Infertility: Management of Infertile Men in Reproductive Medicine offers expert, straightforward guidance on the pathophysiology and management of male infertility for clinicians who assist couples early in the process of trying to conceive.

• Covers diagnostic aspects of male infertility (clinical, laboratory, and imaging methods) as well as various therapeutic options including classical and advanced surgical procedures
• Discusses intrauterine insemination, conventional in vitro fertilization, intracytoplasmic sperm injection, sperm cryopreservation, preimplantation genetic testing, and more
• Begins each chapter with key points and ends with clinical scenarios of real-life problems and their solutions
• Shares the knowledge and expertise of global experts in the field
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud

Ashok Agarwal, PhD, HCLD (ABB), ELD (ACE) is the Head of Andrology Center and Director of Research at the American Center for Reproductive Medicine since 1993. He holds these positions at The Cleveland Clinic Foundation, where he is Professor of Surgery (Urology) at the Lerner College of Medicine of Case Western Reserve University. Ashok was trained in Male Infertility and Andrology at the Brigham and Women’s Hospital and Harvard Medical School and later worked as Assistant Professor of Urology at Harvard from 1988 to 1992. Ashok has over 28 years of experience in directing busy male infertility diagnostic facilities and fertility preservation services. He is very well published with over 735 scientific papers and reviews in peer-reviewed scientific journals and is ranked in Scopus as the #1 author in the world in the fields of Male Infertility/Andrology and Human Assisted Reproduction, based on the number of peer-reviewed publications, citation scores (Scopus: 32,432; Google Scholar: 69,225), and h-index (Scopus: 97; Google Scholar: 128). He is currently an editor of more than 40 medical text books/manuals related to male infertility, ART, fertility preservation, DNA damage, and antioxidants and active in basic and clinical research. His laboratory has trained over 1,000 scientists, clinicians, graduate, and undergraduate students from the United States and more than 55 countries. Ashok is the recipient of over 100 grants totaling over 15 million dollars. His current research interests include proteomics of male infertility and the molecular markers of oxidative stress and DNA integrity in the pathophysiology of male reproduction.

Prof. Dr. Panagiotis Drakopoulos is Visiting Professor at the Centre for Reproductive Medicine (Universitair Ziekenhuis Brussel) in Belgium and Clinical & Scientific of the infertility clinic "I.R.I.S MED" in Herakion, Crete, Greece. He is recognized as a subspecialist in reproductive medicine and surgery by ESHRE (European Society of Human Reproduction and Embryology) and EBCOG (European Board & College of Obstetrics and Gynaecology). He has authored numerous articles in high indexed journals of the field, such as Fertility and Sterility and Human Reproduction. His research focuses on reproductive endocrinology as well as on poor ovarian responders and strategies to improve their outcome.